TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
282,946
|
282,671
|
265,788 |
| Financial expenses |
5,238
|
11,483
|
8,098 |
| Earnings before taxes |
59,690
|
47,140
|
45,257 |
| EBITDA |
65,154
|
49,944
|
47,780 |
| Total assets |
386,994
|
314,471
|
279,773 |
| Current assets |
279,994
|
221,840
|
173,991 |
| Current liabilities |
66,589
|
57,824
|
58,735 |
| Equity capital |
282,156
|
234,390
|
194,672 |
| - share capital |
293
|
293
|
293 |
| Employees (average) |
121
|
122
|
120 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
72.9%
|
74.5%
|
69.6% |
| Turnover per employee |
2,338
|
2,317
|
2,215 |
| Profit as a percentage of turnover |
21.1%
|
16.7%
|
17.0% |
| Return on assets (ROA) |
16.8%
|
18.6%
|
19.1% |
| Current ratio |
420.5%
|
383.6%
|
296.2% |
| Return on equity (ROE) |
21.2%
|
20.1%
|
23.2% |
| Change turnover |
275
|
16,883
|
43,895 |
| Change turnover % |
0%
|
6%
|
20% |
| Chg. No. of employees |
-1
|
2
|
-3 |
| Chg. No. of employees % |
-1%
|
2%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.